ALPS Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-56,991
| Closed | -$896K | – | 1012 |
|
|
2024
Q1 | $896K | Buy |
56,991
+7,292
| +15% | +$115K | 0.01% | 511 |
|
|
2023
Q4 | $802K | Sell |
49,699
-8,516
| -15% | -$137K | 0.01% | 531 |
|
|
2023
Q3 | $740K | Buy |
58,215
+494
| +0.9% | +$6.28K | 0.01% | 542 |
|
|
2023
Q2 | $813K | Buy |
+57,721
| New | +$813K | 0.01% | 529 |
|
|
2020
Q4 | – | Sell |
-71,891
| Closed | -$3.69M | – | 887 |
|
|
2020
Q3 | $3.69M | Sell |
71,891
-4,306
| -6% | -$221K | 0.05% | 177 |
|
|
2020
Q2 | $4.55M | Sell |
76,197
-22,256
| -23% | -$1.33M | 0.06% | 161 |
|
|
2020
Q1 | $4.05M | Sell |
98,453
-4,368
| -4% | -$180K | 0.06% | 158 |
|
|
2019
Q4 | $6.4M | Buy |
102,821
+5,012
| +5% | +$312K | 0.05% | 142 |
|
|
2019
Q3 | $3.32M | Buy |
97,809
+17,884
| +22% | +$607K | 0.03% | 179 |
|
|
2019
Q2 | $1.8M | Buy |
+79,925
| New | +$1.8M | 0.01% | 236 |
|